Boswellia: Benefits, Dosage & What the Science Says

What Is Boswellia?

Boswellia is a resin from trees in the Boswellia genus. Supplements usually use an extract from Boswellia serrata, also called Indian frankincense. The resin contains several boswellic acids. AKBA is one of the best known, but a higher AKBA number is not a guarantee that a product will work better for you. The useful question is whether the finished extract and daily amount match a human study.

The best clinical evidence is for symptoms of knee osteoarthritis. A 2024 independent systematic review found that the combined results varied too much to show a clear overall advantage on two common joint scores. Its placebo subgroup did show a benefit, and the authors called for better trials. An older Cochrane review also found a possible short-term improvement with enriched extracts, but the evidence came from a small number of people and several different products. That makes the signal worth noticing without turning it into certainty.

Extract identity matters. One 2024 review focused on a branded Aflapin extract and reported improvements in pain, stiffness, and function. All three authors listed an affiliation with the company behind that ingredient. That does not erase the findings, but it does mean the result should be read as product-specific evidence that still needs independent comparison. A label that says only frankincense, Boswellia, or total boswellic acids does not tell you that it matches Aflapin, 5-Loxin, or another studied extract.

Boswellia is often explained through 5-lipoxygenase and leukotriene activity. That laboratory mechanism can help explain why researchers study the resin, but a mechanism is not the same thing as a proven result in a person. For a buyer, the human joint trials are more useful than a long list of enzyme claims.

Evidence-Based Benefits

Boswellia for Knee Osteoarthritis Pain

The most useful evidence concerns adults with knee osteoarthritis, not general inflammation. A 2024 systematic review included several Boswellia extract studies. Results were mixed when all studies were pooled because the extracts, doses, trial designs, and outcomes differed. A subgroup against placebo showed a benefit, while the authors still called for larger and better studies. This means Boswellia is reasonable to consider for a measured trial when knee pain is the problem, but the evidence does not promise relief and does not show that every retail extract performs the same way.

^{[PMID:39314013]}

Boswellia for Stiffness and Joint Function

Some trials report easier movement and better function along with less pain. The Cochrane review found moderate-quality evidence for a short-term improvement from one enriched extract, but the main comparison involved a small group. A newer Aflapin review also reported improvements, although its authors were affiliated with the ingredient company. The honest conclusion is narrow: certain studied extracts may help knee symptoms over several weeks. There is not enough evidence to claim that Boswellia repairs cartilage, stops joint damage, or produces the same result as a prescription or over-the-counter pain medicine.

^{[DOI:10.1002/14651858.CD002947.pub2]}

Where the Boswellia Evidence Stops

Joint findings are often stretched into broad promises about the lungs, bowel, immune system, or whole-body inflammation. Those claims are not supported at the same level. Small or older studies in other conditions do not create a general disease claim, and they should not be used to replace medical care. If your pain is new, severe, follows an injury, causes swelling or weakness, or comes with fever, unexplained weight loss, or bowel or breathing symptoms, the useful next step is a medical evaluation rather than a supplement experiment.

^{[PMID:39314013]}

Recommended Dosage

Match the finished extract and daily amount to a human study instead of dosing from the Boswellia name alone. Trials have used very different extracts, so there is no single proven dose for every product. Follow the label, use one product at a time, and ask a pharmacist or clinician to check it when you take medicine.

Safety, Side Effects & Interactions

How to Choose a Quality Boswellia

Start with the front and Supplement Facts labels. The species should be Boswellia serrata. The label should give the finished extract amount per serving, the serving size, and any standardization claim. If a seller connects the product to a named trial, the extract and daily amount should actually match that trial.

Do not choose by the biggest percentage alone. Total boswellic acids and AKBA describe parts of an extract, but the clinical reviews compared finished products that were not interchangeable. A dramatic number on the front label can hide a small serving or an extract that was never studied.

Prefer a single-ingredient product for a first trial. It is easier to judge benefit, side effects, and cost. Look for current independent testing from a recognized program or a lot-specific certificate that checks identity and contaminants. The FDA requires a Supplement Facts panel and ingredient list, but it does not approve each supplement for effectiveness before sale.

Set a useful stopping rule before you start. Write down the joint problem you want to change, such as morning stiffness or walking comfort. Use the same simple measure each week. Stop if side effects appear, the product conflicts with medicine, or there is no meaningful change after the same length of time used in the matching study. That turns the purchase into a decision instead of an open-ended habit.

Works Well With

Research suggests Boswellia may complement:

• Curcumin
• Omega-3 Fish Oil

Traditional Use

Frequently Asked Questions

References

1. 2024 independent systematic review and meta-analysis of Boswellia extracts for knee osteoarthritis - PMID:39314013
2. Cochrane review of oral herbal products for osteoarthritis - DOI:10.1002/14651858.CD002947.pub2
3. 2024 product-specific review of Aflapin for osteoarthritis - PMID:38365549
4. NIH LiverTox safety review for Boswellia serrata - NBK563692
5. FDA questions and answers on dietary supplement labels - FDA-DIETARY-SUPPLEMENTS

Last reviewed: October 18, 2026. For informational purposes only. See full disclaimer. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.